Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Comparison of risperidone and methylphenidate for reducing ADHD symptoms in children and adolescents with moderate mental retardation.

Correia Filho AG, Bodanese R, Silva TL, Alvares JP, Aman M, Rohde LA.

J Am Acad Child Adolesc Psychiatry. 2005 Aug;44(8):748-55.

PMID:
16034276
2.
3.

National survey of adherence, efficacy, and side effects of methylphenidate in children with attention-deficit/hyperactivity disorder in Taiwan.

Gau SS, Chen SJ, Chou WJ, Cheng H, Tang CS, Chang HL, Tzang RF, Wu YY, Huang YF, Chou MC, Liang HY, Hsu YC, Lu HH, Huang YS.

J Clin Psychiatry. 2008 Jan;69(1):131-40.

PMID:
18312048
4.

Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders.

Abikoff H, McGough J, Vitiello B, McCracken J, Davies M, Walkup J, Riddle M, Oatis M, Greenhill L, Skrobala A, March J, Gammon P, Robinson J, Lazell R, McMahon DJ, Ritz L; RUPP ADHD/Anxiety Study Group.

J Am Acad Child Adolesc Psychiatry. 2005 May;44(5):418-27.

PMID:
15843763
5.
6.

Ginkgo biloba for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized controlled trial.

Salehi B, Imani R, Mohammadi MR, Fallah J, Mohammadi M, Ghanizadeh A, Tasviechi AA, Vossoughi A, Rezazadeh SA, Akhondzadeh S.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):76-80. doi: 10.1016/j.pnpbp.2009.09.026. Epub 2009 Oct 5.

PMID:
19815048
7.

Risperidone augmentation for treatment-resistant aggression in attention-deficit/hyperactivity disorder: a placebo-controlled pilot study.

Armenteros JL, Lewis JE, Davalos M.

J Am Acad Child Adolesc Psychiatry. 2007 May;46(5):558-65.

PMID:
17450046
9.
10.

A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit/hyperactivity disorder.

Findling RL, Bukstein OG, Melmed RD, López FA, Sallee FR, Arnold LE, Pratt RD.

J Clin Psychiatry. 2008 Jan;69(1):149-59. Erratum in: J Clin Psychiatry. 2008 Feb;69(2):329.

PMID:
18312050
11.

Is age-at-onset criterion relevant for the response to methylphenidate in attention-deficit/hyperactivity disorder?

Reinhardt MC, Benetti L, Victor MM, Grevet EH, Belmonte-de-Abreu P, Faraone SV, Rohde LA.

J Clin Psychiatry. 2007 Jul;68(7):1109-16.

PMID:
17685750
12.

Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.

Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK.

Clin Ther. 2007 Jun;29(6):1168-77.

PMID:
17692731
14.

A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.

Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, Pearl PL, Black DO, Seymour KE, Newcorn JH.

Pediatrics. 2003 Nov;112(5):e404.

PMID:
14595084
15.

A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder.

Wigal S, Swanson JM, Feifel D, Sangal RB, Elia J, Casat CD, Zeldis JB, Conners CK.

J Am Acad Child Adolesc Psychiatry. 2004 Nov;43(11):1406-14.

PMID:
15502600
16.

Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs.

Snyder R, Turgay A, Aman M, Binder C, Fisman S, Carroll A; Risperidone Conduct Study Group.

J Am Acad Child Adolesc Psychiatry. 2002 Sep;41(9):1026-36.

PMID:
12218423
17.

Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.

Posey DJ, Aman MG, McCracken JT, Scahill L, Tierney E, Arnold LE, Vitiello B, Chuang SZ, Davies M, Ramadan Y, Witwer AN, Swiezy NB, Cronin P, Shah B, Carroll DH, Young C, Wheeler C, McDougle CJ.

Biol Psychiatry. 2007 Feb 15;61(4):538-44.

PMID:
17276750
18.

Risperidone-to-methylphenidate switch reaction in children: three cases.

Sabuncuoglu O.

J Psychopharmacol. 2007 Mar;21(2):216-9. Erratum in: J Psychopharmacol. 2008 Aug;22(6):699.

PMID:
17329303
19.

Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study.

Huang YS, Guilleminault C, Li HY, Yang CM, Wu YY, Chen NH.

Sleep Med. 2007 Jan;8(1):18-30. Epub 2006 Dec 6.

PMID:
17157069
20.

Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo.

Levin FR, Evans SM, Brooks DJ, Kalbag AS, Garawi F, Nunes EV.

Drug Alcohol Depend. 2006 Feb 1;81(2):137-48. Epub 2005 Aug 15.

PMID:
16102908

Supplemental Content

Support Center